Lcz696 Injection, Solution
NDC Package 52076-6259-2
Package Information
Lcz696 injection is teduglutide is used by patients with Short Bowel Syndrome (SBS) who need intravenous (IV) nutrition and fluids. This formulation utilizes a injection, solution delivery system. Marketed by Chunghwa Chemical Synthesis & Biotech. Ltd, this product is identified by NDC 52076-6259.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 52076 - Chunghwa Chemical Synthesis & Biotech. Ltd
- 52076-6259 -
- 52076-6259-2 - 50 kg in 1 VIAL, GLASS
- 52076-6259 -
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (52076-6259). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 52076-6259-2 identifies a specific commercial package of 50 kg in 1 vial, glass of Lcz696 (UNFINISHED drug), a bulk ingredient labeled by Chunghwa Chemical Synthesis & Biotech. Ltd. This injection, solution is formulated for use and contains teduglutide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chunghwa Chemical Synthesis & Biotech. Ltd on February 22, 2016. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Teduglutide is used by patients with Short Bowel Syndrome (SBS) who need intravenous (IV) nutrition and fluids. It may help to decrease the amount of intravenous nutrition needed by the patient. Teduglutide is similar to a natural hormone in your body (GLP-2). It works by helping to improve intestinal absorption of fluids and nutrients.
How is this Chunghwa Chemical Synthesis & Biotech. Ltd product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 52076625902. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.